Here are four additional notes on Aurora Spine’s second-quarter financial results, according to an Aug. 21 news release from the company:
1. The company’s second quarter benefitted from a high demand in the pain management sector, specifically for the SiLO TFX and ZIP 51 implants.
2. The company’s gross margins improved to 62.4% in the second quarter of 2024, up from 56.9% in the same period last year.
3. Operating expenses for the second quarter were $2.74 million, up from $2.51 million in 2023.
4. The Company reported a net loss of $(0.154) million for the quarter, narrowing from a net loss of $(0.482) million in 2023.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
